Immunocore Holdings (IMCR) Cash from Operations Growth (3y) (2024 - 2026)
Immunocore Holdings (IMCR) Cash from Operations Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - | -5.07% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.85 Bn | 467.06 Bn | 1.35 Bn | 33.08% |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn | 16.64% |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.28 Bn | 3.31 Bn | -7.60% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.47 Bn | 959.66 Mn | 34.32% |
| 10 | Immunocore Holdings | 1.76 Bn | 913.00 Mn | 106.24 Mn | -48.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48.99% |
| Dec 31, 2025 | -87.72% |
| Sep 30, 2025 | -35.12% |
| Dec 31, 2024 | 28.84% |